Citing a ‘conflict,’ GSK vet Slaoui abruptly quits Intellia board
Not long after retiring from GlaxoSmithKline, where he led R&D and then the vaccines group, Moncef Slaoui started signing up for a variety of biotech …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
